DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

NASDAQ:DHCNL • US25525P3055

18.41 USD
+0.13 (+0.71%)
Last: Feb 26, 2026, 03:13 PM
Fundamental Rating

2

Taking everything into account, DHCNL scores 2 out of 10 in our fundamental rating. DHCNL was compared to 122 industry peers in the Diversified REITs industry. DHCNL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DHCNL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DHCNL has reported negative net income.
  • DHCNL had a positive operating cash flow in the past year.
  • DHCNL had negative earnings in 4 of the past 5 years.
  • In multiple years DHCNL reported negative operating cash flow during the last 5 years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

  • The Return On Assets of DHCNL (-7.52%) is worse than 89.34% of its industry peers.
  • With a Return On Equity value of -20.85%, DHCNL is not doing good in the industry: 84.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • DHCNL has a worse Gross Margin (17.58%) than 94.26% of its industry peers.
  • In the last couple of years the Gross Margin of DHCNL has declined.
  • DHCNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

  • DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DHCNL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.35, we must say that DHCNL is in the distress zone and has some risk of bankruptcy.
  • DHCNL has a Altman-Z score (0.35) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that DHCNL has dependencies on debt financing.
  • DHCNL's Debt to Equity ratio of 1.61 is on the low side compared to the rest of the industry. DHCNL is outperformed by 62.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC6.69%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • DHCNL has a Current Ratio of 6.66. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of DHCNL (6.66) is better than 97.54% of its industry peers.
  • DHCNL has a Quick Ratio of 6.66. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
  • DHCNL's Quick ratio of 6.66 is amongst the best of the industry. DHCNL outperforms 97.54% of its industry peers.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 6.66
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

  • DHCNL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.38%, which is quite good.
EPS 1Y (TTM)12.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.01%

3.2 Future

  • Based on estimates for the next years, DHCNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.39% on average per year.
  • The Revenue is expected to grow by 3.88% on average over the next years.
EPS Next Y36.87%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.64%
Revenue Next 2Y3.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

  • DHCNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHCNL is valued more expensive than 91.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.11
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DHCNL's earnings are expected to grow with 18.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.39%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.66%, DHCNL is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 6.87, DHCNL's dividend is way lower than its industry peers. On top of this 92.62% of the companies listed in the same industry pay a better dividend than DHCNL!
  • With a Dividend Yield of 0.66, DHCNL pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

  • The dividend of DHCNL decreases each year by -45.60%.
  • DHCNL has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years0
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of DHCNL are negative and hence is the payout ratio. DHCNL will probably not be able to sustain this dividend level.
DP-2.74%
EPS Next 2Y18.39%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (2/26/2026, 3:13:46 PM)

18.41

+0.13 (+0.71%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners76.96%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.46B
Revenue(TTM)N/A
Net Income(TTM)-352.11M
Analysts74.29
Price Target17.2 (-6.57%)
Short Float %0.02%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)-3.77%
PT rev (3m)-8.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.9
P/FCF N/A
P/OCF 238.56
P/B 2.64
P/tB 2.64
EV/EBITDA 29.11
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY0.42%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 11.41
Cap/Depr 65.29%
Cap/Sales 11.78%
Interest Coverage N/A
Cash Conversion 7.83%
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 6.66
Altman-Z 0.35
F-Score6
WACC6.69%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y36.87%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.01%
Revenue Next Year3.64%
Revenue Next 2Y3.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.47%
EBIT Next 3Y74.06%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 / DHCNL FAQ

What is the ChartMill fundamental rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNL.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a profitability rating of 1 / 10.


What is the earnings growth outlook for DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is expected to grow by 36.87% in the next year.


How sustainable is the dividend of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

The dividend rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 1 / 10 and the dividend payout ratio is -2.74%.